Stacy Price
Chief Tech/Sci/R&D Officer bij INVIVYD, INC.
Vermogen: - $ op 31-03-2024
Profiel
Stacy Price is currently the Chief Technology & Manufacturing Officer at Invivyd, Inc. Prior to this role, Stacy held positions as the Senior Vice President-Technical Operations at Alaunos Therapeutics, Inc. and Chief Technical Officer at Akouos, Inc. Stacy has also received undergraduate and graduate degrees from Tufts University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 18-12-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Stacy Price
| Bedrijven | Functie | Begin |
|---|---|---|
| INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 01-03-2023 |
Eerdere bekende functies van Stacy Price
| Bedrijven | Functie | Einde |
|---|---|---|
| AKOUOS | Chief Tech/Sci/R&D Officer | - |
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Stacy Price
| Tufts University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
